162 related articles for article (PubMed ID: 24489757)
1. Ultrasound molecular imaging of secreted frizzled related protein-2 expression in murine angiosarcoma.
Tsuruta JK; Klauber-DeMore N; Streeter J; Samples J; Patterson C; Mumper RJ; Ketelsen D; Dayton P
PLoS One; 2014; 9(1):e86642. PubMed ID: 24489757
[TBL] [Abstract][Full Text] [Related]
2. Optimizing ultrasound molecular imaging of secreted frizzled related protein 2 expression in angiosarcoma.
Tsuruta JK; Schaub NP; Rojas JD; Streeter J; Klauber-DeMore N; Dayton P
PLoS One; 2017; 12(3):e0174281. PubMed ID: 28333964
[TBL] [Abstract][Full Text] [Related]
3. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
[TBL] [Abstract][Full Text] [Related]
4. A novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth.
Fontenot E; Rossi E; Mumper R; Snyder S; Siamakpour-Reihani S; Ma P; Hilliard E; Bone B; Ketelsen D; Santos C; Patterson C; Klauber-DeMore N
Mol Cancer Ther; 2013 May; 12(5):685-95. PubMed ID: 23604067
[TBL] [Abstract][Full Text] [Related]
5. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
[TBL] [Abstract][Full Text] [Related]
6. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.
Garcia D; Nasarre P; Bonilla IV; Hilliard E; Peterson YK; Spruill L; Broome AM; Hill EG; Yustein JT; Mehrotra S; Klauber-DeMore N
Ann Surg Oncol; 2019 Dec; 26(13):4782-4790. PubMed ID: 31515721
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model.
Lutz AM; Bachawal SV; Drescher CW; Pysz MA; Willmann JK; Gambhir SS
Clin Cancer Res; 2014 Mar; 20(5):1313-22. PubMed ID: 24389327
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer.
Wischhusen J; Wilson KE; Delcros JG; Molina-Peña R; Gibert B; Jiang S; Ngo J; Goldschneider D; Mehlen P; Willmann JK; Padilla F
Theranostics; 2018; 8(18):5126-5142. PubMed ID: 30429890
[TBL] [Abstract][Full Text] [Related]
9. Development of antibody-carrying microbubbles based on clinically available ultrasound contrast agent for targeted molecular imaging: a preliminary chemical study.
Otani K; Yamahara K
Mol Imaging Biol; 2011 Apr; 13(2):250-6. PubMed ID: 20512420
[TBL] [Abstract][Full Text] [Related]
10. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
[TBL] [Abstract][Full Text] [Related]
11. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound.
Brückner M; Heidemann J; Nowacki TM; Cordes F; Stypmann J; Lenz P; Gohar F; Lügering A; Bettenworth D
World J Gastroenterol; 2017 Apr; 23(16):2899-2911. PubMed ID: 28522908
[TBL] [Abstract][Full Text] [Related]
14. Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway.
Courtwright A; Siamakpour-Reihani S; Arbiser JL; Banet N; Hilliard E; Fried L; Livasy C; Ketelsen D; Nepal DB; Perou CM; Patterson C; Klauber-Demore N
Cancer Res; 2009 Jun; 69(11):4621-8. PubMed ID: 19458075
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
16. Rapid Copper-free Click Conjugation to Lipid-Shelled Microbubbles for Ultrasound Molecular Imaging of Murine Bowel Inflammation.
Goncin U; Bernhard W; Curiel L; Geyer CR; Machtaler S
Bioconjug Chem; 2022 May; 33(5):848-857. PubMed ID: 35427123
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles.
Zhang H; Ingham ES; Gagnon MK; Mahakian LM; Liu J; Foiret JL; Willmann JK; Ferrara KW
Biomaterials; 2017 Feb; 118():63-73. PubMed ID: 27940383
[TBL] [Abstract][Full Text] [Related]
18. Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy.
Sorace AG; Saini R; Mahoney M; Hoyt K
J Ultrasound Med; 2012 Oct; 31(10):1543-50. PubMed ID: 23011617
[TBL] [Abstract][Full Text] [Related]
19. Nanobody-coupled microbubbles as novel molecular tracer.
Hernot S; Unnikrishnan S; Du Z; Shevchenko T; Cosyns B; Broisat A; Toczek J; Caveliers V; Muyldermans S; Lahoutte T; Klibanov AL; Devoogdt N
J Control Release; 2012 Mar; 158(2):346-53. PubMed ID: 22197777
[TBL] [Abstract][Full Text] [Related]
20. Accelerated blood clearance of targeted ultrasound contrast reduced molecular imaging signal intensity: Secreted Frizzled Related Protein-2 signal remained significantly higher than signal from either Vascular Endothelial Growth Factor Receptor-2 or alpha
Tsuruta J; White R; Klauber-DeMore N; Dayton PA
IEEE Int Ultrason Symp; 2019 Oct; 2019():407-410. PubMed ID: 34650779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]